HSBC Innovation Banking: Q1 2025 Venture Numbers for Healthcare
- blonca9
- Apr 4
- 1 min read
HSBC's Jonathan Norris shares an update on Q1 venture numbers for healthcare, and how the venture side of the sector is holding up in these volatile times.
Also look for unique social pages for BiotechTV U.
Evaluate is a trusted provider of forecasting and commercial intelligence to the pharmaceutical industry. With a combination of gold standard data sources and deep pharma expertise, Evaluate helps clients make the right portfolio decisions to drive growth.
Evaluate's solutions provide a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, underpinned by consensus forecasts to 2032, pipelines, deals and more. A consulting and analytics team is on always hand to help clients address unique clinical and commercial challenges.